title: Cardiovascular Outcome Trials in Diabetes: Will the EMPA-REG OUTCOME and LEADER Trials Influence Clinical Decisions in Type 2 Diabetes?
authors.affiliation: LMC Diabetes & Endocrinology, Brampton, Ontario, Canada; Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Ontario, Canada.
authors.forename: Harpreet Singh
authors.initials: HS
authors.lastname: Bajaj
authors.affiliation: Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Ontario, Canada; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; Division of Endocrinology, University of Toronto, Toronto, Ontario, Canada. Electronic address: zinman@lunenfeld.ca.
authors.forename: Bernard
authors.initials: B
authors.lastname: Zinman
mesh_terms: D002318:Cardiovascular Diseases / Q000150:complications* / Q000188:drug therapy / Q000517:prevention & control; D000066491:Clinical Decision-Making; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D017410:Practice Guidelines as Topic; D016896:Treatment Outcome